Neonatal Respiratory Distress Syndrome Treatment Market
Because of the difficulty in breathing and coughing caused by the breathing tube, oxygen therapy and mechanical ventilation therapy are associated with an increased risk of pneumonia in neonates. There is a risk of bradycardia and hypoxemia during surfactant therapy in neonates. Furthermore, the cost of neonatal ventilation is high and may be prohibitively expensive for many patients in developing countries such as India. These factors are expected to limit the growth of the global neonatal respiratory distress syndrome treatment market.
Read More:
https://knackersblogger.blogspot.com/2022/08/neonatal-respiratory-distress-syndrome.html
